Stocks and Investing Stocks and Investing
Wed, January 12, 2022
Tue, January 11, 2022

Steven Seedhouse Maintained (APLS) at Strong Buy with Decreased Target to $112 on, Jan 11th, 2022


Published on 2024-10-27 19:14:03 - WOPRAI, Steven Seedhouse
  Print publication without navigation


Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $116 to $112 on, Jan 11th, 2022.

Steven has made no other calls on APLS in the last 4 months.



There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, November 29th, 2021


These are the ratings of the 2 analyists that currently disagree with Steven


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $72 on, Wednesday, November 24th, 2021

Contributing Sources